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Supplementary Data 1
Detailed Analytical Parameters
1 Cut-off and internal standards concentrations
In Table 1, [IS] is the concentration of internal standard (IS) in the IS solution added to samples,
not the final concentration in the sample.
Table 1: Analyte and internal standards concentrations
Analyte Cut-off Internal Standard [IS]
(ng/mL) (ng/mL)
Alprazolam 8 Lorazepam-D4 3300
α-Hydroxyalprazolam 20 Triazolam-D4 1100
Amitriptyline 30 Amitriptyline-D3 440
Amphetamine 15 Amphetamine-D8 1100
Aripiprazole 10 Trazodone-D6 550
Bromazepam 75 Bromazepam-D4 4950
Buprenorphine 5 Oxycodone-D3 1100
Bupropion 15 Ephedrine-D3 1100
Hydroxybupropion 20 Ephedrine-D3 1100
Chlordiazepoxide 15 Chlordiazepoxide-D5 1100
Citalopram 30 Citalopram-D6 440
N-Desmethylcitalopram 20 Citalopram-D6 440
Clobazam 15 Flunitrazepam-D7 220
N-Desmethylclobazam 20 Flunitrazepam-D7 220
Clonazepam 8 Flunitrazepam-D7 220
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Table 1: Analyte and internal standards concentrations
Analyte Cut-off Internal Standard [IS]
(ng/mL) (ng/mL)
7-Aminoclonazepam 8 7-Aminoclonazepam-D4 1100
Cocaethylene 8 Cocaine-D3 550
Cocaine 8 Cocaine-D3 550
Benzoylecgonine 8 Cocaine-D3 550
Codeine 5 Codeine-D3 1100
Norcodeine 20 Codeine-D3 1100
Cyclobenzaprine 30 Amitriptyline-D3 440
N-Desmethylcyclobenzaprine 20 Amitriptyline-D3 440
Demoxepam 15 Demoxepam-D5 1100
Dextromethorphane 15 Oxymorphone-D3 1100
Dextrorphane 20 Oxycodone-D3 1100
Diazepam 8 Diazepam-D5 1100
Nordiazepam 8 Diazepam-D5 1100
Diphenhydramine 30 Diphenhydramine-D3 2200
N-Desmethyldiphenhydramine 20 Diphenhydramine-D3 2200
Duloxetine 20 Amitriptyline-D3 440
EDDP 30 Diphenhydramine-D3 2200
Ephedrine 15 Ephedrine-D3 1100
Fentanyl 0.5 Fentanyl-D5 110
Acetyl fentanyl 1.5 Fentanyl-D5 110
Norfentanyl 0.5 Fentanyl-D5 110
Flunitrazepam 15 Flunitrazepam-D7 220
7-Aminoflunitrazepam 20 7-Aminoclonazepam-D4 1100
N-Desmethylflunitrazepam 20 Desalkylflurazepam-D4 1100
Fluoxetine 30 Amitriptyline-D3 440
Norfluoxetine 20 Amphetamine-D8 1100
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Table 1: Analyte and internal standards concentrations
Analyte Cut-off Internal Standard [IS]
(ng/mL) (ng/mL)
Flurazepam 6 Lorazepam-D4 3300
Desalkylflurazepam 30 Desalkylflurazepam-D4 1100
2-Hydroxyethylflurazepam 20 Lorazepam-D4 3300
Hydrocodone 5 Oxycodone-D3 1100
Hydromorphone 5 Oxymorphone-D3 1100
Ketamine 30 Ketamine-D4 1320
Norketamine 20 Ketamine-D4 1320
Lorazepam 30 Lorazepam-D4 3300
mCPP 20 Amphetamine-D8 1100
MDA 20 Amphetamine-D8 1100
MDEA 20 MDMA-D5 77
MDMA 15 MDMA-D5 77
MDPV 15 MDPV-D8 1100
MDPV metabolite 1 20 MDPV-D8 1100
Meperidine 15 Cocaine-D3 550
Normeperidine 40 Codeine-D3 1100
Methadone 10 Amitriptyline-D3 440
Methamphetamine 15 Methamphetamine-D5 110
Midazolam 15 Lorazepam-D4 3300
α-Hydroxymidazolam 20 Diazepam-D5 1100
Mirtazapine 30 Amitriptyline-D3 440
N-Desmethylmirtazapine 20 Amitriptyline-D3 440
Morphine 5 Morphine-D6 1100
6-Acetylmorphine 2 Codeine-D3 1100
Naloxone 20 Oxymorphone-D3 1100
Naltrexone 20 Oxycodone-D3 1100
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Table 1: Analyte and internal standards concentrations
Analyte Cut-off Internal Standard [IS]
(ng/mL) (ng/mL)
Nitrazepam 15 Nitrazepam-D5 1100
7-Aminonitrazepam 15 7-Aminoclonazepam-D4 1100
Nortriptyline 15 Amitriptyline-D3 440
Olanzapine 15 Olanzapine-D8 220
N-Desmethylolanzapine 20 Olanzapine-D8 220
Oxazepam 8 Oxazepam-D5 220
Oxycodone 5 Oxycodone-D3 1100
Oxymorphone 5 Oxymorphone-D3 1100
Paroxetine 15 Amitriptyline-D3 440
PCP 6 PCP-D5 220
Procyclidine 15 Citalopram-D6 440
Pseudoephedrine 15 Ephedrine-D3 1100
Quetiapine 30 Quetiapine-D8 440
Norquetiapine 20 Quetiapine-D8 440
7-Hydroxyquetiapine 20 Quetiapine-D8 440
Risperidone 15 Trazodone-D6 550
9-Hydroxyrisperidone 15 Trazodone-D6 550
Rolicyclidine 9 Diphenhydramine-D3 2200
Sertraline 9 Amitriptyline-D3 440
Temazepam 30 Lorazepam-D4 3300
THC 1.5 THC-D3 110
Tramadol 10 Tramadol-D3 2200
O-Desmethyl-cis-tramadol 10 Tramadol-D3 2200
Trazodone 30 Trazodone-D6 550
Triazolam 15 Triazolam-D4 1100
α-Hydroxytriazolam 20 Triazolam-D4 1100
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Table 1: Analyte and internal standards concentrations
Analyte Cut-off Internal Standard [IS]
(ng/mL) (ng/mL)
Venlafaxine 30 Venlafaxine-D6 2200
O-Desmethylvenlafaxine 30 Venlafaxine-D6 2200
Zopiclone 9 Zopiclone-D4 1100
N-Desmethylzopiclone 20 Zopiclone-D4 1100
2 General method
2.1 Liquid chromatography
Mobile phase A: methanol : 10 mM Ammonium formate pH 3.0 (2:98 v:v)
Mobile phase B: acetonitrile (LC-MS Grade)
Rinsing solution: methanol : 1% formic acid in water : isopropanol (50:25:25 v:v:v)
Analytical column: Zorbax Eclipse Plus C18, 2.1× 100 mm, 3.5 μm (Agilent)
Flow rate: 650 μL/min
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Table 2: LC Pump Gradient











2.2 Autosampler and thermostat Settings
• Injection volume: 5 μL
• Wash time: 10 sec
• Autosampler temperature: 4 ◦C
• Column oven temperature: 50 ◦C
6







2.3 Mass spectrometry method
• Scan type: scheduled multiple reaction monitoring (MRM)
• Polarity: positive
• MRM detection window: 45 sec
• Target scan time: 0.6 sec
• Break: 3.00 msec
• Acquisition time: 13 minutes
• Ion source: Turbo Spray
• Curtain Gas (CUR): 30.0
• Collision Gas (CAD): 10.0
• Ion Spray Voltage (IS): 3000.0 V
• Source temperature (TEM): 700.0 ◦C
• Ion Source Gas 1 (GS1): 60.0
• Ion Source Gas (GS2): 65.0
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
309.1 205.0 8.6 Alprazolam 1 140 10 50 15
311.1 283.1 8.6 Alprazolam 2 140 10 37 12
325.1 297.2 8.0 α-Hydroxyalprazolam 1 110 10 38 11
325.1 216.1 8.0 α-Hydroxyalprazolam 2 110 10 56 18
279.2 118.0 8.3 Amitriptyline 1 76 10 32 11
279.2 106.0 8.3 Amitriptyline 2 76 10 30 11
136.1 119.0 3.5 Amphetamine 1 40 10 13 10
136.1 91.1 3.5 Amphetamine 2 40 10 28 10
448.1 285.1 8.3 Aripiprazole 1 80 10 37 10
448.1 176.1 8.3 Aripiprazole 2 80 10 42 11
290.1 105.0 4.5 Benzoylecgonine 1 70 10 26 10
290.1 82.0 4.5 Benzoylecgonine 2 70 10 25 10
316.0 182.2 7.0 Bromazepam 1 100 10 45 18
316.0 209.1 7.0 Bromazepam 2 100 10 38 18
240.1 139.0 5.7 Bupropion 1 55 10 29 10
240.1 103.0 5.7 Bupropion 2 55 10 45 10
256.1 130.1 5.0 Hydroxybupropion 1 50 10 48 12
256.1 103.1 5.0 Hydroxybupropion 2 50 10 49 18
300.1 227.1 6.5 Chlordiazepoxide 1 65 10 35 20
300.1 165.1 6.5 Chlordiazepoxide 2 65 10 70 13
326.2 235.0 7.2 Citalopram 1 85 10 40 15
326.2 263.1 7.2 Citalopram 2 85 10 22 15
312.2 110.1 7.1 N-Desmethylcitalopram 1 70 10 30 15
312.2 263.1 7.1 N-Desmethylcitalopram 2 70 10 24 25
301.1 224.1 9.1 Clobazam 1 100 10 47 15
301.1 259.0 9.1 Clobazam 2 100 10 20 15
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
287.1 245.0 8.3 N-Desmethylclobazam 1 100 10 28 15
287.1 210.0 8.3 N-Desmethylclobazam 2 100 10 42 13
316.1 270.0 8.3 Clonazepam 1 90 10 36 15
316.1 214.0 8.3 Clonazepam 2 90 10 53 19
286.1 250.1 4.9 7-Aminoclonazepam 1 80 10 30 18
286.1 94.1 4.9 7-Aminoclonazepam 2 80 10 56 13
305.2 183.1 5.3 Cocaine 1 30 10 21 15
304.2 91.0 5.3 Cocaine 2 30 10 38 12
319.2 197.1 6.1 Cocaethylene 1 100 10 20 15
318.2 150.0 6.1 Cocaethylene 2 100 10 28 15
300.2 215.0 3.4 Codeine 1 110 10 36 18
300.2 152.0 3.4 Codeine 2 110 10 91 18
286.1 115.0 3.3 Norcodeine 1 100 10 90 15
286.1 128.0 3.3 Norcodeine 2 100 10 80 15
277.2 232.1 8.0 Cyclobenzaprine 1 85 10 19 15
276.1 115.1 8.0 Cyclobenzaprine 2 85 10 33 12
263.2 216.0 8.0 N-Desmethylcyclobenzaprine 1 60 10 51 17
263.2 232.0 8.0 N-Desmethylcyclobenzaprine 2 60 10 22 21
287.1 241.0 7.4 Demoxepam 1 100 10 50 15
287.1 115.1 7.4 Demoxepam 2 100 10 33 15
273.2 216.1 6.7 Dextromethorphane 1 120 10 35 20
273.2 172.0 6.7 Dextromethorphane 2 120 10 52 15
259.2 158.1 4.8 Dextrorphan 1 85 10 53 17
259.8 115.0 4.8 Dextrorphan 2 85 10 83 15
285.1 89.0 9.8 Diazepam 1 45 10 70 15
285.1 223.1 9.8 Diazepam 2 45 10 37 12
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
298.1 154.0 8.2 Duloxetine 1 60 10 9 9
298.1 44.0 8.2 Duloxetine 2 60 10 50 10
271.1 140.0 8.9 Nordiazepam 1 95 10 42 13
271.1 165.1 8.9 Nordiazepam 2 95 10 39 15
256.2 115.0 7.0 Diphenhydramine 1 55 10 70 10
256.2 128.1 7.0 Diphenhydramine 2 55 10 70 10
243.1 168.1 6.9 N-Desmethyldiphenhydramine 1 40 10 20 15
243.1 153.1 6.9 N-Desmethyldiphenhydramine 2 40 10 50 15
279.2 250.1 7.5 EDDP 1 100 10 26 15
279.2 116.0 7.5 EDDP 2 100 10 95 13
166.1 133.0 2.9 Ephedrine 1 40 10 29 12
166.1 117.0 2.9 Ephedrine 2 40 10 29 10
337.2 188.2 6.8 Fentanyl 1 110 10 34 17
337.2 105.1 6.8 Fentanyl 2 110 10 55 14
233.2 84.1 4.6 Norfentanyl 1 60 10 26 10
233.2 150.1 4.6 Norfentanyl 2 60 10 25 13
323.2 188.2 5.9 Acetyl fentanyl 1 100 10 33 14
323.2 105.0 5.9 Acetyl fentanyl 2 100 10 55 12
314.1 268.1 8.8 Flunitrazepam 1 100 10 36 12
314.1 183.0 8.8 Flunitrazepam 2 100 10 75 15
284.1 240.0 5.5 7-Aminoflunitrazepam 1 120 10 51 20
284.1 226.1 5.5 7-Aminoflunitrazepam 2 120 10 40 20
300.1 254.0 7.9 N-Desmethylflunitrazepam 1 85 10 36 15
300.1 198.1 7.9 N-Desmethylflunitrazepam 2 85 10 55 15
310.1 148.0 8.6 Fluoxetine 1 40 10 10 15
310.1 44.0 8.6 Fluoxetine 2 130 10 23 10
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
296.1 134.2 8.5 Norfluoxetine 1 65 10 10 10
296.1 296.1 8.5 Norfluoxetine 2 65 10 5 10
389.2 316.0 7.1 Flurazepam 1 100 10 35 20
389.2 134.0 7.1 Flurazepam 2 100 10 75 16
289.1 140.0 8.8 Desalkylflurazepam 1 110 10 40 15
289.1 226.1 8.8 Desalkylflurazepam 2 110 10 40 12
333.1 211.1 8.5 2-Hydroxyethylflurazepam 1 120 10 51 15
333.1 109.1 8.5 2-Hydroxyethylflurazepam 2 120 10 40 14
300.2 128.2 3.9 Hydrocodone 1 90 10 78 15
300.2 115.0 3.9 Hydrocodone 2 90 10 85 14
286.1 185.1 2.2 Hydromorphone 1 120 10 40 15
286.1 157.0 2.2 Hydromorphone 2 120 10 58 20
239.1 126.0 4.6 Ketamine 1 64 10 43 12
239.1 208.1 4.6 Ketamine 2 64 10 21 16
224.1 179.3 4.5 Norketamine 1 70 10 20 15
224.1 126.0 4.5 Norketamine 2 70 10 35 20
321.0 275.0 8.3 Lorazepam 1 70 10 31 15
321.0 229.1 8.3 Lorazepam 2 70 10 72 15
197.1 154.1 4.9 mCPP 1 75 10 20 13
197.1 118.0 4.9 mCPP 2 75 10 29 14
180.1 79.0 3.7 MDA 1 50 10 40 12
180.1 135.0 3.7 MDA 2 50 10 26 12
209.1 164.0 4.4 MDEA 1 60 10 14 15
209.1 136.1 4.4 MDEA 2 601 10 30 15
195.1 164.1 4.0 MDMA 1 60 10 20 15
195.1 106.1 4.0 MDMA 2 60 10 35 10
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
277.2 176.1 5.3 MDPV 1 75 10 31 15
277.2 127.1 5.3 MDPV 2 75 10 35 15
279.2 176.1 4.6 MDPV metabolite 1 50 10 23 20
279.2 127.2 4.6 MDPV metabolite 2 50 10 23 15
249.2 22.1 5.4 Meperidine 1 80 10 31 20
249.2 175.2 5.4 Meperidine 2 80 10 27 13
235.1 161.1 5.5 Normeperidine 1 60 10 22 15
234.1 115.1 5.5 Normeperidine 2 60 10 85 11
311.2 266.0 8.4 Methadone 1 80 10 15 10
311.2 224.2 8.4 Methadone 2 80 10 31 20
151.1 120.1 3.8 Methamphetamine 1 65 10 15 10
150.1 91.0 3.8 Methamphetamine 2 40 10 15 10
326.1 291.0 7.0 Midazolam 1 85 10 30 12
326.1 249.0 7.0 Midazolam 2 85 10 53 12
342.1 168.1 7.3 α-Hydroxymidazolam 1 110 10 55 15
342.1 140.0 7.3 α-Hydroxymidazolam 2 110 10 84 12
267.2 210.1 5.2 Mirtazapine 1 90 10 33 10
266.2 115.0 5.2 Mirtazapine 2 90 10 50 15
253.2 196.2 5.0 N-Desmethylmirtazapine 1 70 10 31 15
252.2 209.2 5.0 N-Desmethylmirtazapine 2 70 10 22 20
286.1 152.1 1.7 Morphine 1 100 10 79 14
286.1 165.0 1.7 Morphine 2 100 10 60 15
328.2 165.0 4.0 6-Acetylmorphine 1 80 10 55 10
328.2 211.0 4.0 6-Acetylmorphine 2 80 10 37 10
328.2 212.2 3.4 Naloxone 1 100 10 55 15
328.2 253.2 3.4 Naloxone 2 100 10 38 15
12
Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
342.2 270.1 3.9 Naltrexone 1 100 10 38 15
342.2 212.0 3.9 Naltrexone 2 100 10 60 20
282.2 236.0 8.0 Nitrazepam 1 100 10 36 15
282.2 207.0 8.0 Nitrazepam 2 100 10 50 11
252.1 146.0 3.6 7-Aminonitrazepam 1 100 10 40 14
253.1 122.1 3.6 7-Aminonitrazepam 2 100 10 37 15
265.2 234.2 8.1 Nortriptyline 1 80 10 20 10
265.2 192.0 8.1 Nortriptyline 2 80 10 35 10
314.1 257.0 4.0 Olanzapine 1 40 10 26 25
313.1 282.0 4.0 Olanzapine 2 40 10 38 10
299.1 213.1 3.9 N-Desmethylolanzapine 1 140 10 30 11
299.1 198.1 3.9 N-Desmethylolanzapine 2 140 10 42 12
287.1 241.1 8.1 Oxazepam 1 60 10 30 20
287.1 104.1 8.1 Oxazepam 2 60 10 45 12
316.2 256.1 3.7 Oxycodone 1 95 10 35 15
316.2 241.0 3.7 Oxycodone 2 95 10 42 15
302.1 284.0 1.9 Oxymorphone 1 90 10 22 16
302.1 227.0 1.9 Oxymorphone 2 90 10 41 12
330.2 70.0 7.8 Paroxetine 1 100 10 45 10
330.2 109.0 7.8 Paroxetine 2 100 10 75 10
244.2 159.1 6.3 PCP 1 50 10 20 20
244.2 91.0 6.3 PCP 2 50 10 35 10
152.1 117.1 2.3 Phenylpropanolamine 1 40 10 23 12
152.1 91.0 2.3 Phenylpropanolamine 2 40 10 47 16
288.2 42.0 7.7 Procyclidine 1 90 10 75 10
289.2 85.2 7.7 Procyclidine 2 90 10 30 10
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
166.1 133.0 3.1 Pseudoephedrine 1 45 10 29 12
166.1 117.0 3.1 Pseudoephedrine 2 45 10 28 11
385.2 248.1 7.1 Quetiapine 1 70 10 55 15
385.2 280.1 7.1 Quetiapine 2 70 10 40 20
297.1 140.1 6.9 Norquetiapine 1 70 10 80 15
297.1 184.0 6.9 Norquetiapine 2 70 10 53 15
401.1 270.0 4.7 7-Hydroxyquetiapine 1 30 10 35 18
401.1 209.1 4.7 7-Hydroxyquetiapine 2 30 10 60 20
411.2 110.0 6.1 Risperidone 1 90 10 56 15
411.2 163.0 6.1 Risperidone 2 90 10 68 15
427.2 179.2 5.7 9-Hydroxyrisperidone 1 110 10 60 15
427.2 165.2 5.7 9-Hydroxyrisperidone 2 110 10 60 15
230.2 72.0 6.0 Rolicyclidine 1 50 10 18 10
230.2 159.0 6.0 Rolicyclidine 2 50 10 18 12
306.1 123.1 8.7 Sertraline 1 50 10 75 15
306.1 275.1 8.7 Sertraline 2 50 10 12 15
301.1 177.0 9.0 Temazepam 1 65 10 43 17
302.1 256.1 9.0 Temazepam 2 65 10 23 15
264.2 42.0 5.0 Tramadol 1 80 10 75 10
265.2 59.0 5.0 Tramadol 2 80 10 45 10
250.2 58.0 4.0 O-Desmethyl-cis-tramadol 1 150 10 90 10
250.2 42.0 4.0 O-Desmethyl-cis-tramadol 2 70 10 105 14
373.2 177.1 6.2 Trazodone 1 50 10 25 14
373.2 149.1 6.2 Trazodone 2 90 10 37 15
343.1 204.2 8.7 Triazolam 1 100 10 70 18
343.1 177.2 8.7 Triazolam 2 100 10 90 15
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
359.0 331.0 8.0 α-Hydroxytriazolam 1 100 10 40 10
359.0 176.0 8.0 α-Hydroxytriazolam 2 100 10 38 16
278.2 147.1 6.0 Venlafaxine 1 60 10 25 13
279.2 216.2 6.0 Venlafaxine 2 60 10 24 16
264.2 201.2 4.6 O-Desmethylvenlafaxine 1 60 10 25 20
264.2 107.0 4.6 O-Desmethylvenlafaxine 2 60 10 27 15
389.1 245.0 4.9 Zopiclone 1 60 10 26 10
389.1 217.0 4.9 Zopiclone 2 60 10 47 16
375.1 245.1 4.9 N-Desmethylzopiclone 1 70 10 25 10
375.1 217.0 4.9 N-Desmethylzopiclone 2 70 10 50 10
281.2 117.0 8.3 Amitriptyline-D3 76 10 32 11
144.1 127.0 3.4 Amphetamine-D8 40 10 13 10
320.0 186.2 6.9 Bromazepam-D4 100 10 45 18
305.1 232.2 6.4 Chlordiazepoxide-D5 65 10 35 20
331.2 234.0 7.2 Citalopram-D6 85 10 40 15
209.1 254.0 4.8 7-Aminoclonazepam-D4 80 10 30 18
308.2 185.0 5.3 Cocaine-D3 30 10 21 15
303.3 215.0 3.5 Codeine-D3 110 10 36 18
292.1 246.2 7.3 Demoxepam-D5 100 10 50 15
290.1 89.0 9.8 Diazepam-D5 45 10 70 15
259.2 115.0 7.0 Diphenhydramine-D3 55 10 80 10
169.1 136.0 2.9 Ephedrine-D3 40 10 29 12
342.2 188.2 6.8 Fentanyl-D5 110 10 34 17
321.1 275.1 8.7 Flunitrazepam-D7 100 10 36 12
293.1 140.0 8.8 Desalkylflurazepam-D4 110 10 40 15
244.1 131.0 4.6 Ketamine-D4 64 10 43 12
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
327.1 281.0 8.3 Lorazepam-D4 70 10 33 15
199.1 165.1 4.0 MDMA-D5 60 10 20 15
285.2 175.1 5.3 MDPV-D8 75 10 31 15
155.1 121.1 3.8 Methamphetamine-D5 65 10 15 10
292.1 152.1 1.7 Morphine-D6 100 10 79 14
287.1 185.1 8.0 Nitrazepam-D5 100 10 50 10
321.1 261.1 4.0 Olanzapine-D8 40 10 26 25
292.1 246.1 8.1 Oxazepam-D5 60 10 30 14
319.2 259.0 3.8 Oxycodone-D3 95 10 35 15
305.2 287.0 1.9 Oxymorphone-D3 90 10 22 16
249.2 164.2 6.3 PCP-D5 50 10 20 20
392.2 254.0 7.0 Quetiapine-D8 70 10 55 15
268.2 42.0 5.0 Tramadol-D3 80 10 75 10
379.2 182.1 6.2 Trazodone-D6 90 10 35 14
347.1 208.0 8.7 Triazolam-D4 100 10 70 18
284.2 147.0 6.0 Venlafaxine-D6 60 10 34 13
393.1 245.0 4.9 Zopiclone-D4 60 10 26 10
Q1: parent mass; Q3: fragment mass; DP: declustering potential; EP: entrance potential; CE:
collision energy; CXP: collision cell exit potential. Transition 1 is the “identification transition”,




Mobile phase A: methanol : 10 mM Ammonium formate pH 3.0 (2:98 v:v)
Mobile phase B: acetonitrile (LC-MS Grade)
Rinsing solution: methanol : 1% formic acid in water : isopropanol (50:25:25 v:v:v)
Analytical column: Zorbax Eclipse Plus C18, 2.1× 50 mm, 3.5 μm (Agilent)
Flow rate: 550 μL/min
Table 5: LC Pump Gradient












3.2 Autosampler and thermostat Settings
• Injection volume: 10 μL
• Wash time: 10 sec
• Autosampler temperature: 4 ◦C
• Column oven temperature: 50 ◦C
3.3 Mass spectrometry method







• Scan type: scheduled multiple reaction monitoring (MRM)
• Polarity: positive
• MRM detection window: 60 sec
• Target scan time: 0.6 sec
• Break: 3.00 msec
• Acquisition time: 6 minutes 30 seconds
• Ion source: Turbo Spray
• Curtain Gas (CUR): 30.0
• Collision Gas (CAD): 10.0
• Ion Spray Voltage (IS): 5500.0 V
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• Source temperature (TEM): 700.0 ◦C
• Ion Source Gas 1 (GS1): 60.0
• Ion Source Gas (GS2): 65.0
Table 7: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
315.2 193.1 4.8 THC 1 100 10 30 15
315.2 123.1 4.8 THC 2 100 10 47 10
318.3 196.1 4.8 THC-D3 100 10 30 15
The method is validated on the following systems: HPLC Agilent 1200 series and 1260 Infinity,
LC-MS/MS 5500 QTRAP Sciex.
The data acquisition software used is Analyst R© 1.6.2 build 8489 and the data analysis software
used is Multiquant R© 3.0.1 (Version 3.0.6256.0)
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